# 1. Target: GSR
7 regulons containing the target(s), GSR are overactive in this patient.
None
# 1. Target: RRM2
12 regulons containing the target(s), RRM2 are overactive in this patient.
None
2 regulons containing the target(s), TYMS are overactive in this patient.
HALLMARK_E2F_TARGETS HALLMARK_G2M_CHECKPOINT HALLMARK_MYC_TARGETS_V1 HALLMARK_MITOTIC_SPINDLE HALLMARK_MTORC1_SIGNALING
No additional evidence was found
2 regulons containing the target(s), ALK are overactive in this patient.
None
No additional evidence was found
# 1. Target: MAOB
3 regulons containing the target(s), MAOB are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
2 regulons containing the target(s), TYMS are overactive in this patient.
HALLMARK_E2F_TARGETS HALLMARK_G2M_CHECKPOINT HALLMARK_MYC_TARGETS_V1 HALLMARK_MITOTIC_SPINDLE HALLMARK_MTORC1_SIGNALING
No additional evidence was found
2 regulons containing the target(s), ALK are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
2 regulons containing the target(s), SV2A are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
4 regulons containing the target(s), KEAP1 are overactive in this patient.
None
No additional evidence was found
2 regulons containing the target(s), VKORC1 are overactive in this patient.
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
7 regulons containing the target(s), GSR are overactive in this patient.
None
No glioblastoma clinical trials were found for these drugs.
5 regulons containing the target(s), ABL1 are overactive in this patient.
No glioblastoma clinical trials were found for these drugs.
1 regulons containing the target(s), LOXL2 are overactive in this patient.
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
2 regulons containing the target(s), BSG are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
5 regulons containing the target(s), NDUFA13 are overactive in this patient.
HALLMARK_OXIDATIVE_PHOSPHORYLATION HALLMARK_DNA_REPAIR HALLMARK_MYC_TARGETS_V1
No glioblastoma clinical trials were found for these drugs.
2 regulons containing the target(s), TSG101 are overactive in this patient.
HALLMARK_OXIDATIVE_PHOSPHORYLATION HALLMARK_DNA_REPAIR HALLMARK_MYC_TARGETS_V1
No glioblastoma clinical trials were found for these drugs.
4 regulons containing the target(s), NOTCH1 are overactive in this patient.
HALLMARK_NOTCH_SIGNALING HALLMARK_WNT_BETA_CATENIN_SIGNALING
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
17 regulons containing the target(s), ABAT are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
3 regulons containing the target(s), CHKA are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
2 regulons containing the target(s), NQO1 are overactive in this patient.
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
2 regulons containing the target(s), PLA2G2A are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
1 regulons containing the target(s), ELN are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
1 regulons containing the target(s), TRPV4 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
12 regulons containing the target(s), RRM2 are overactive in this patient.
None
No glioblastoma clinical trials were found for these drugs.
10 regulons containing the target(s), EEF2 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
18 regulons containing the target(s), MAPK1,MAPK3 are overactive in this patient.
None
No additional evidence was found
27 regulons containing the target(s), HSPA8 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
66 regulons containing the target(s), ATP1A1 are overactive in this patient.
HALLMARK_TNFA_SIGNALING_VIA_NFKB HALLMARK_UV_RESPONSE_DN HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION HALLMARK_TGF_BETA_SIGNALING
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
7 regulons containing the target(s), PLA2G2A,PLA2G5 are overactive in this patient.
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION HALLMARK_TNFA_SIGNALING_VIA_NFKB
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
13 regulons containing the target(s), SLC6A9 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
35 regulons containing the target(s), APP are overactive in this patient.
No glioblastoma clinical trials were found for these drugs.
5 regulons containing the target(s), SOD1 are overactive in this patient.
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
5 regulons containing the target(s), ACVR2B are overactive in this patient.
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
9 regulons containing the target(s), OXTR are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
***Warning message: Missing column names filled in: ‘X15’ [15], ‘X16’ [16], ‘X17’ [17], ‘X18’ [18], ‘X19’ [19], ‘X20’ [20], ‘X21’ [21], ‘X22’ [22], ‘X23’ [23], ‘X24’ [24], ‘X25’ [25], ‘X26’ [26], ‘X27’ [27], ‘X28’ [28], ‘X29’ [29], ‘X30’ [30], ‘X31’ [31], ‘X32’ [32], ‘X33’ [33], ‘X34’ [34], ‘X35’ [35], ‘X36’ [36], ‘X37’ [37], ‘X38’ [38], ‘X39’ [39], ‘X40’ [40], ‘X41’ [41], ‘X42’ [42], ‘X43’ [43], ‘X44’ [44], ‘X45’ [45], ‘X46’ [46], ‘X47’ [47], ‘X48’ [48], ‘X49’ [49], ‘X50’ [50], ‘X51’ [51], ‘X52’ [52], ‘X53’ [53], ‘X54’ [54], ‘X55’ [55], ‘X56’ [56], ‘X57’ [57], ‘X58’ [58], ‘X59’ [59], ‘X60’ [60], ‘X61’ [61], ‘X62’ [62], ‘X63’ [63], ‘X64’ [64], ‘X65’ [65], ‘X66’ [66], ‘X67’ [67], ‘X68’ [68], ‘X69’ [69], ‘X70’ [70], ‘X71’ [71], ‘X72’ [72], ‘X73’ [73], ‘X74’ [74], ‘X75’ [75], ‘X76’ [76], ‘X77’ [77], ‘X78’ [78], ‘X79’ [79], ‘X80’ [80], ‘X81’ [81], ‘X82’ [82], ‘X83’ [83], ‘X84’ [84], ‘X85’ [85], ‘X86’ [86], ‘X87’ [87], ‘X88’ [88], ‘X89’ [89], ‘X90’ [90], ‘X91’ [91], ‘X92’ [92], ‘X93’ [93], ‘X94’ [94], ‘X95’ [9 [… truncated]